首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells
【2h】

MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells

机译:MicroRNA-96通过靶向FOXO1和调节AKT / FOXO1 / Bim途径在甲状腺乳头状癌细胞中发挥致癌作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are kind of small non-coding RNAs that negatively regulate gene expression at post-transcription level, and those non-coding RNAs appear to play a key role in tumorigenesis. The aim of this study was to investigate the biological role of miR-96 in papillary thyroid carcinoma (PTC) cell lines. We identified miR-96 to be up-regulated in PTC specimens in comparison to matched normal tissues by microRNA microarray and RT-qPCR analysis (P < 0.05). Next, to explore the potential function of miR-96, PTC cell lines K1 and TPC1 were transiently transfected with miR-96 mimics and inhibitor. Successful transfection being confirmed by RT-qPCR. Ectopic expression of miR-96 promoted proliferation and colony formation ability, and inhibited apoptosis of K1 and TPC1 cells, whereas down-regulated expression of miR-96 suppressed those functions when compared with the control cells. According to a computational prediction, FOXO1 maybe a potential target of miR-96. Luciferase assays revealed that miR-96 is directly targeted to both binding sites of FOXO1 3’-untranslated region (3’-UTR) and suppressed the FOXO1 expression, and subsequently inhibited the expression of Bim protein in PTC cells. Moreover, the expression of FOXO1 had an inverse correlation with expression of miR-96 in PTC specimens by RT-qPCR and western blot analysis. The data from the present study demonstrated that miR-96 can promote proliferation, and inhibit apoptosis in PTC cell lines K1 and TPC1, thus miR-96 may play an oncogenic role in PTC by inhibiting the FOXO1 and regulating AKT/FOXO1/Bim pathway, and it may serve as a novel therapeutic target for miRNA-based PTC therapy.
机译:微小RNA(miRNA)是一种小的非编码RNA,在转录后水平上负调控基因的表达,而这些非编码RNA似乎在肿瘤发生中起关键作用。这项研究的目的是调查miR-96在甲状腺乳头状癌(PTC)细胞系中的生物学作用。通过microRNA芯片和RT-qPCR分析,我们发现与匹配的正常组织相比,PTC标本中的miR-96上调(P <0.05)。接下来,为了探索miR-96的潜在功能,用miR-96模拟物和抑制剂瞬时转染PTC细胞系K1和TPC1。 RT-qPCR证实成功转染。 miR-96的异位表达促进了K1和TPC1细胞的增殖和集落形成能力,并抑制了其凋亡,而与对照细胞相比,miR-96的下调表达抑制了这些功能。根据计算预测,FOXO1可能是miR-96的潜在靶标。萤光素酶检测显示,miR-96直接靶向FOXO1 3'非翻译区(3'-UTR)的两个结合位点,并抑制FOXO1表达,随后抑制PTC细胞中Bim蛋白的表达。此外,通过RT-qPCR和western blot分析,FOXO1的表达与PTC标本中的miR-96的表达呈负相关。来自本研究的数据表明,miR-96可以促进PTC细胞K1和TPC1的增殖并抑制其凋亡,因此miR-96可能通过抑制FOXO1和调节AKT / FOXO1 / Bim途径在PTC中发挥致癌作用,它可以作为基于miRNA的PTC治疗的新型治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号